Clinical Trial

New Diagnostic Tool (MinION) for Identifying Microorganisms in Foot Wounds of Patients Living With Diabetic Foot Osteomyelitis

Study acronym: MINI-OS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 11, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
Diabetic foot wound infections are predominantly polymicrobial. However, 'conventional' microbiological culture does not identify all the bacteria potentially involved in these infections and requires time, which can have a negative impact by delaying treatment and/or the prescription of appropriate antibiotic therapy. Real-time metagenomics analysis using Oxford Nanopore Technologies' MinION technology has demonstrated sufficient power to identify virtually all microbial genomes in a given sample, providing additional information on their antibiotic resistance profile and in silico prediction of genes encoding virulence factors within than 4 hours. Based on these rapid results, a management protocol could be defined specifically for each patient with a view to personalised medicine. The aim is to study the diversity of bacterial and fungal species identified using the MinION method and compare this diversity with the results obtained using conventional methods (routine culture) from bone biopsies taken from DFOM patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-28.
Trial Details
NCT Number NCT07391995
Lead Sponsor Centre Hospitalier Universitaire de Nīmes
Conditions Diabetes Mellitus, Diabetes Complications, Diabetic Peripheral Neuropathy
Enrollment 43 participants
Start Date 2026-01-01
Primary Completion 2026-06 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-11